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Background: To measure the use, satisfaction and impact of a web portal which provides patients with
rheumatoid arthritis home access to their electronic medical records (EMR).
Methods: A pretest-posttest study was conducted among 360 patients. Questionnaires assessed socio-demographics,
health literacy, Internet use, disease characteristics, patient-provider relationship and empowerment before and after
launching a hospital-based patient web portal. To measure the impact of the portal, patients’ satisfaction with care, trust
in their rheumatologist, self-efficacy in patient-provider communication, illness perceptions, and medication adherence
were assessed. The post-test included questions on portal use, satisfaction, and self-perceived impact due to portal use.
Results: 54% of respondents with Internet access had viewed their EMR. Respondents were positive about the
ease of use and usefulness of the portal and reported very few problems. Age (P = .03), amount of Internet use
(P = .01) and self-perceived Internet skills (P = .03) significantly predicted portal use. Of the respondents who had
logged in, 44% reported feeling more involved in their treatment and 37% felt they had more knowledge about
their treatment. Significant differences over time were not found on the empowerment-related instruments.
Conclusions: The current portal succeeded in offering patients access to their EMR in a usable and
understandable way. While its true impact is difficult to grasp, a relevant portion of the patients felt more involved
in their treatment due to the web portal. Offering patients home EMR access, therefore, appears to be a valuable
addition to the care process.
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Since many rheumatic diseases are chronic and can have
a large impact on patients’ lives, it is essential that patients
become involved in their treatment and have proper self-
care practices [1,2]. Increasing patients’ responsibilities
and autonomy is also essential for the redesign of health
services, from current disease- or institutional-centered
models to patient-centered models of care, in order to
keep expenses under control [3,4]. The implementation of
information and communication technologies in health
care can play an essential role in this shift [5]. A slowly* Correspondence: r.vandervaart@fsw.leidenuniv.nl
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distribution, and reproduction in any mediumemerging technology in health care is the ability to provide
patients online home-access to their electronic medical
records (EMRs), via hospital-based patient web portals
[6,7]. The key benefit of this application is that patients
can (repeatedly) read the documentation on their disease
and treatment, at home, which has the potential to em-
power patients in their care process [8,9].
Providing patients home EMR-access may influence
health care on several levels. First of all, it increases
transparency of medical data, which could reduce medical
errors, increase patients’ trust in care providers and could
enhance patient satisfaction [10-12]. Secondly, patients’
knowledge and understanding of the disease and treat-
ment may be enhanced [13], increasing their involvement
in decision making processes [13,14]. Thirdly, patientsentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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which could positively influence treatment adherence
[15], and even clinical outcomes [16].
While patient access to medical records could benefit
health care, an online application might not suit everyone.
Previous studies have shown that users of online applica-
tions are often relatively young and highly educated [17].
Furthermore, patients’ abilities to use (online) health infor-
mation, also called “health literacy” is assumed to be re-
lated to acceptance of online applications [18]. Until now,
little is known about the predictors for using home access
to medical records or on the difficulties that patients
experience when using this service.
Hospitals increasingly offer patients home access to
their EMR, but to the best of our knowledge, no studies
have thus far been conducted in the field of rheumatol-
ogy. Still, previous studies have shown that patients are
indeed interested in this option [19,20], and both rheu-
matologists and nurses believe that it could have a posi-
tive impact on the empowerment of their patients [21].
Based upon these studies, a web portal was designed
following user-centered design principles [22], whichFigure 1 Screenshot of a login page providing rheumatoid arthritis doffers information on rheumatic diseases, treatments, and
available aids and support (www.reumacentrumtwente.nl).
Additionally, the patient web portal contains a personal
secure login section, where patients can find their diag-
nosis, current medication and medication history, blood
results, actual and previous disease activity, and out-
comes on quality of life related instruments. All data is
accompanied by written information and (where pos-
sible) charts and graphs to show the fluctuation in
scores along a timeline using colors to compare the data
to norm scores. A screenshot of one of the patient web
portal pages can be found in Figure 1. The purpose of
this study was to assess the use, satisfaction, and the im-
pact of the portal on the patient-provider relationship
and patient empowerment, among patients suffering
from rheumatoid arthritis.Methods
A pretest-posttest design was used, conducting a survey in
the month before the web portal went online (T0), and
five months after (T1).isease activity (DAS28) scores with an explanation of the data.
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In total, 415 patients diagnosed with RA, conform the
1987 American College of Rheumatology classification
criteria, were selected from the patient database of the
Arthritis Centre Twente in Enschede, the Netherlands.
Treating rheumatologists (n = 6) were asked to exclude
those patients from the selection who were deceased
(n = 10), or had had their last consultation longer than
one year ago (n = 24). Other reasons for rheumatolo-
gists to exclude patients were: not diagnosed with RA
(n = 3), severe co-morbidity (n = 4) or change of hos-
pital (n = 1). In total, 42 patients were excluded. The
373 remaining patients were sent a personal invitation
letter and a paper-and-pencil questionnaire on T0. A
reminder was sent to those patients who did not re-
spond within two weeks. One invitation was returned
as undeliverable and 6 patients called or e-mailed to
report that they were not interested in participation.
After the pretest, all (but these 7) patients received an
invitation to visit the portal and to log in with a per-
sonal account, which could be obtained in person in
the clinic. Five months later, the same sample was
approached with a personal letter and posttest ques-
tionnaire, with a reminder after 2 weeks, excluding the
7 patients that had withdrawn (n = 366). At T1, four
questionnaires were returned as undeliverable and two
patients were deceased, resulting in 360 patients that
received questionnaires on both T0 and T1. This study
did not need approval of the ethical review board.Instruments
To investigate predictors of patient web portal use, the
questionnaire on T0 comprised of socio-demographics
(age, gender, education level, marital status, and employ-
ment), health literacy [23,24], Internet use (access, quantity
of use and self-perceived skills), and disease characteristics
(moment of diagnosis, number of clinic visits in the past
6 months, self-perceived general health).
To investigate the impact of the patient web portal, five
validated instruments were included on which change
could be expected due to the use of the portal. Satisfaction
with care was measured by items based on the QUOTE
rheumatic patients [25]. Six items were used measuring
satisfaction with the rheumatologist and the nurse practi-
tioner, respectively. Response options ranged from “not at
all” (1) to “definitely” (4). The possible range of scores for
both scales was 6 to 24, with 24 representing a high satis-
faction with care. Cronbach’s alphas were .83 and .87 re-
spectively. Trust in the rheumatologist was measured with
the Trust In Physicians short form (TRIP_sf), which is
based on the Cologne-Patient-Questionnaire scale “trust
in physicians” and which measures different aspects of a
trusting physician-patient-interaction [26]. Items could beanswered using a 5-point Likert scale ranging from “do
not agree at all” (1) to “completely agree” (5), with a
possible score ranging from 5 to 20, with 20 represent-
ing a high trust in the rheumatologist. Cronbach’s alpha
was .93. Self-efficacy in patient-provider communication
was assessed with the 5-item version of the Perceived
Efficacy in Patient-Physician Interactions questionnaire
(PEPPI-5), which assesses the subjective sense of pa-
tients’ confidence when interacting with their physicians
[27]. The instrument has been translated and validated
for the Dutch situation [28]. Participants respond to
each question on a 5-point Likert scale ranging from
“not at all confident” (1) to “very confident” (5). The range
of possible scores is 5 to 25, with 25 representing the high-
est patient self-efficacy. Cronbach’s alpha of this instrument
was .96 in our data. Illness perception was assessed with
the Revised Illness Perception Questionnaire (IPQ-R). The
subscales ‘Personal control’ (6 items), ‘Treatment control’
(5 items), and ‘Illness coherence’ (5 items) were used,
which assess personal control and self-efficacy beliefs,
belief in the treatment, and understanding of the illness,
respectively [29]. All items can be answered on a 5-
point Likert scale ranging from “strongly disagree” (1)
to “strongly agree” (5), which makes the possible range
of scores 6 – 30 and 5 – 25, with 30 and 25 representing
the highest perceived control. Cronbach’s alphas of the
subscales were .52, .72, and .76, respectively. Medication
adherence was assessed with the Morisky Medication
Adherence scale (MMA), which measures medication-
taking behavior using eight items. Response categories
are yes/no for seven dichotomous items and a 5-point
Likert response ranging from “always” (1) to “never” (5)
for the last item, which was dichotomized [30,31].
Scores were recoded, so that higher scores represent a
better medication adherence, with eight representing
perfect adherence. Cronbach’s alpha was .66.
The questionnaire on T1 comprised of the same mea-
sures as the pre-test, except for health literacy. To as-
sess use and satisfaction with the patient web portal,
several questions were added to the post-test, including:
(1) use and moment of use of the website section and
login section of the portal, (2) sharing of the personal
information from the portal with others, (3) perceived
ease of use, clarity, usefulness and completeness of the
portal, (4) problems encountered on the portal, and
what was done to solve them, (5) difficulties with under-
standing information in the login section, and (6) occur-
rence of wrong information in the login section.
Additionally, questions were asked on the self-perceived
impact of the portal. These questions covered the same
constructs as the aforementioned instruments, but
asked patients directly if they felt that the portal caused
an increase, decrease, or did not change anything con-
cerning these outcomes.
Table 1 Patient web portal usage of respondents at T1
(n = 214)






n (%) n (%)
Respondents who used the web
portal
115 (54) 111 (70)
1 time 41 (19) 38 (24)
2 times 47 (22) 46 (29)
3 times or more 27 (13) 27 (17)
Respondents who used the website
only
29 (14) 26 (16)
Respondents who logged in 86 (40) 85 (54)
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Analyses were performed using the Statistical Package
for the Social Sciences (IBM SPSS Statistics 20). To
analyze differences in age and gender at baseline be-
tween patients who did return the questionnaire at T0
and/or T1 and those who did not, the Mann–Whitney
test was applied for age and the chi-square for gender.
Descriptive statistics were used to summarize socio-
demographics, Internet-related and disease characteris-
tics, portal use and satisfaction, and perceived impact of
the portal. To explore relationships between patient
characteristics and portal usage (non-use, website only
use, and login use), the Kruskal-Wallis test was applied
for continuous variables and the chi-square for discrete
variables. Whenever a significant difference was found,
pairwise comparisons were performed to further analyze
differences between groups, using Mann–Whitney or
chi-square tests. Additionally, multi-nominal logistic re-
gression was used to analyze which variables uniquely
predicted patient web portal use. To analyze the effect
of portal use, Analysis of Covariance was used, in which
scores on T1 of non-users, website users and login users
were compared, including their T0 scores as covariate.
For all analyses, p-values <0.01 (two-tailed) were used




Of the 372 patients who received the questionnaire at
T0, 259 (70%) sent it back completed. At T1, 360 patients
were sent the questionnaire, of which 214 (59%) com-
pleted it. A total of 194 (54%) patients completed both
questionnaires. There were no differences in age or gender
between responders and non-responders on T0. At T1
and in the paired samples, there were no differences
between responders and non-responders in gender,
but the mean age of responders was 4.2 years higher
(P = .01) and 3.6 years higher (P = .02), respectively.
Patient web portal use
Of all respondents on T1, more than half (54%) reported
to have used the portal, and 86 respondents (40%) re-
ported to have logged in to view their personal informa-
tion (Table 1). Of all respondents with Internet access,
70% had used the portal and 54% had logged in. Lack of
Internet access was the most frequent reason for not
using the portal (n = 56). Other reasons not to have used
the portal were: “I planned to but didn’t have time yet”
(n = 30), “I’m not interested” (n = 19), “I tried, but some-
thing went wrong” (n = 7), and “I don’t know how to visit
the portal” (n = 5).
Of the respondents who logged in on the portal, 60
(70%) reported to do this in the week before a consultationwith their rheumatologist or nurse practitioner. Sixteen re-
spondents (19%) reported doing this after their consult-
ation (data not shown in Table). Of the respondents who
logged in on the portal, 29 (34%) shared their personal in-
formation with a family member.
Predictors of patient web portal use
Table 2 shows the personal and Internet-related character-
istics of the respondents at T1. The overall mean age was
62 (SD = 13.3), ranging from 20 to 86 years old. Two
thirds of the respondents were female, which is represen-
tative for our population. Overall, respondents reported
using the Internet regularly, but only a minority (31%)
rated their own Internet skills as “good” to “very good”.
Univariate analyses showed that age, marital status, educa-
tion level, employment, health literacy and all Internet-
related characteristics were significantly related to portal
usage. Non users were more often older, single, lower edu-
cated and unemployed. Respondents with a higher level of
health literacy were more inclined to log in on the portal,
as well as respondents who used the Internet more often,
had more years of experience, and perceived their own
skills as better.
Table 3 shows an overview of health-related character-
istics of the respondents on T1. Most patients had been
diagnosed with RA for more than a year, and visited the
rheumatology clinic regularly. The majority of respon-
dents perceived their general health as good or excellent.
None of these characteristics were significantly related
to portal use.
Further analyses with multi-nominal logistic regres-
sion, showed that all variables together explained 59% of
the variance (R2 = .59 (Nagelkerke), model χ2(22) = 94.04,
P < .001). Patient web portal use was significantly predicted
by age (b = .09, Wald χ2(1) = 4.72, P = .03), with youn-
ger respondents being more inclined to use the portal.
Logging in at the portal was significantly predicted by
self-perceived Internet skills (b = −.96, Wald χ2(1) = 4.74,
Table 2 Personal and Internet-related characteristics of respondents on T1 and differences between patient web portal
users and non-users (n = 214)
Characteristic Total(n = 214) Non-users (n = 99) Website users (n = 29) Login users (n = 86) P1
Age (M, (SD)) 62 (13.2) 66 (14)ac 63 (11)ab 56 (11)bc .000
Gender (% female) 140 (65%) 69 (70%) 14 (48%) 57 (66%) n.s.
Marital status (% living together) 170 (80%) 68 (70%)ac 26 (90%)a 76 (88%)c .000
Education level
low 86 (40%) 54 (55%)ac 8 (28%)a 24 (28%)c .001
medium 89 (42%) 29 (29%) 15 (52%) 45 (52%)
high 33 (15%) 11 (11%) 6 (21%) 16 (19%)
missing 6 (3%) 4 (4%) - 1 (1%)
Employment (% working) 72 (34%) 24 (24%)c 10 (34%) 38 (44%)c .02
Health literacy (M(SD)) (n = 157)2 38.6 (7.2) 36.5 (7.6)c 37.9 (7.2) 40.9 (6.1)c .001
Internet-related
Amount of Internet use
Daily/several days a week 117 (55%) 27 (27%)c 17 (59%)b 73 (85%)cb .000
One day a week or less 50 (23%) 30 (30%) 9 (31%) 11 (13%)
Missing (no home Internet access) 47 (22%) 43 (43%) 3 (10%) 1 (1%)
Years of Internet experience
< 5 years 44 (21%) 21 (21%)c 10 (34%)b 13 (15%)cb .001
≥ 5 years 113 (53%) 26 (26%) 16 (55%) 71 (83%)
Missing 57 (27%) 52 (53%) 3 (10%) 2 (2%)
Self-perceived Internet skills
Good to very good 66 (31%) 11 (11%)c 6 (21%)b 49 (57%)cb .000
Average to reasonable 75 (35%) 28 (28%) 16 (55%) 31 (36%)
Poor 22 (10%) 13 (13%) 5 (17%) 4 (5%)
Missing 51 (24%) 47 (47%) 2 (7%) 2 (2%)
1Kruskal-Wallis or Chi-square tests.
2Scale ranges from 14 (low level of health literacy) to 56 (high level of health literacy); data from T0.
aSignificant difference between non-users and website users.
bSignificant difference between website users and login users.
cSignificant difference between non-users and login users.
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(1) = 6.07, P = .01).
Satisfaction with the patient web portal
The portal was positively appraised and most login users
found their personal information “fairly easy” to “very
easy” to understand (Table 4). When logging in to the
portal, 15 respondents experienced a single problem. As
a result, three respondents left the portal, three asked
for help, and nine kept trying until they succeeded. Two
respondents reported reoccurring problems when logging
in to the portal. One of them requested a new account,
and one called the web host. Nine respondents who had
logged in to the portal reported finding incorrect
information. In all cases, this concerned medication or
blood test information that was outdated. Three res-
pondents mentioned this during a consultation with
their doctor and one participant called the hospital.Five respondents reported not taking any action (yet)
because: “I thought it wasn’t important”, “I didn’t know
who to contact”, and “I was too insecure to contact
anyone”.
Subjective impact of the patient web portal
Several positive changes were perceived by patients who
had logged on to the portal (Table 5). A large part of the
respondents felt that they were more involved in their
treatment and that they understood their treatment bet-
ter due to the patient web portal. One third of all login
users felt that the quality of care was higher as a result
of the portal. Also, according to a large part of the re-
spondents, knowledge about the disease, understanding
of what care providers explain, communication with the
care providers, and trust in the care providers was in-
creased. Additionally, some patients reported to search
less for health information by themselves, as a result of
Table 3 Health-related characteristics of respondents at T1 and differences between portal users and non-users
(n = 214)
Characteristics Total (n = 214) Non-users (n = 99) Website users (n = 29) Login users (n = 86) P1
Time since diagnosis
< 5 years ago 150 (70%) 67 (68%) 22 (76%) 61 (71%) n.s.
≥ 5 years ago 60 (28%) 28 (28%) 7 (24%) 25 (29%)
missing 4 (2%) 4 (4%) - -
Number of clinic visits in the past 6 months
0 - 1 66 (31%) 36 (36%) 8 (28%) 22 (26%) n.s.
2 118 (55%) 53 (54%) 16 (55%) 49 (57%)
3 or more 23 (11%) 5 (5%) 4 (14%) 14 (16%)
Missing 7 (3%) 5 (5%) 1 (3%) 1 (1%)
Self-perceived general health
Good to excellent 126 (59%) 54 (55%) 20 (69%) 52 (60%) n.s.
Reasonable to poor 86 (40%) 43 (43%) 9 (31%) 34 (40%)
Missing 2 (1%) 2 (2%) - -
1Chi-square tests.
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Only one participant perceived a negative change, he/
she felt less involved in the treatment due to the patient
web portal. No further adverse effects were reported by
the participants.Table 5 Perceived impact of the patient web portal
according to users (n = 115)
Empowerment-related variables Website users
(n = 29) n (%)
Login users
(n = 86) n (%)
Using the patient web portal increased
my …
Involvement in the treatment 1 (3%) 38 (44%)Pre-post test results on impact of the patient web portal
Analyses of Covariance revealed that the T1 scores on
the impact outcome measures did not differ among the
three groups (non-users, website only users and login
users) (Table 6). Website users and login users did not
show a larger improvement in the patient-providerTable 4 Appraisal, comprehension and accuracy of the
login part of the patient web portal (n = 86)
M (S.D.) n (%)
Appraisal of the login part (n = 64-75)1




Comprehension of the login pages (n = 63-72)2
DAS28 (disease activity) 3.4 (.7)
Medication (history) 3.5 (.6)
Blood results 3.5 (.5)
Feedback on monitored data 3.5 (.6)
Encountered problems when logging in on the patient web portal
1 problem 15 (17)
2 problems 2 (2)
Found incorrect (our-of-date) information 9 (10)
1Answer options ranged from 1 (very negative) to 5 (very positive).
2Answer options ranged from 1 (very difficult) to 4 (very easy).relationship and on empowerment than non-users did,
as we would have expected. It should be noted, however,
that ceiling effects at T0 were found for four out of eight
outcome measures. A ceiling effect is present when at
least 15% of respondents scored the highest possibleKnowledge about the treatment 2 (7%) 32 (37%)
Quality of care 2 (7%) 25 (29%)
Knowledge about the disease 2 (7%) 21 (24%)
Understanding of what care
providers explain
- 21 (24%)
Self-efficacy in communication with
care providers
- 16 (19%)
Trust in my care provider - 14 (16%)
Insight into the need of medication
therapy
1 (3%) 12 (14%)
Medication adherence - 8 (9%)
Communication with others about
my disease
- 6 (7%)
Number of online searches for
health information
- 4 (5%)
Using the patient web portal decreased
my …
Number of online searches for
health information
- 15 (17%)
Worries about my health 1 (3%) 3 (3%)
Involvement in the treatment - 1 (1%)
Table 6 Effects of the website and login part on empowerment-related outcomes (n = 214)
Non-users Website users Login users P1
(n = 52–81) (n = 18–24) (n = 68–80)
T0 T1 T0 T1 T0 T1
Satisfaction with rheumatologist2 22.3 (2.3) 22.6 (2.3) 21.9 (2.1) 23.0 (1.6) 22.4 (2.1) 22.6 (2.0) n.s.
Satisfaction with nurse2 22.5 (2.4) 22.6 (2.4) 21.9 (2.1) 23.0 (2.0) 22.4 (2.5) 22.8 (2.0) n.s.
Trust in the rheumatologist3 17.1 (2.2) 17.5 (2.3) 16.8 (2.3) 16.3 (3.2) 17.3 (2.3) 17.4 (2.3) n.s.
Perceived self-efficacy in patient-provider communication4 21.3 (3.1) 21.8 (3.3) 20.7 (2.8) 20.9 (3.2) 21.2 (3.5) 21.3 (3.2) n.s.
Illness perception
Personal control5 18.8 (2.8) 18.9 (3.4) 19.0 (2.9) 19.4 (3.1) 19.3 (3.3) 19.6 (3.9) n.s.
Illness coherence4 16.1 (3.1) 16.2 (3.6) 16.5 (3.6) 17.7 (3.8) 17.5 (3.7) 17.4 (3.5) n.s.
Treatment control4 18.8 (2.6) 18.5 (3.0) 18.9 (3.1) 18.8 (2.0) 19.0 (2.6) 19.2 (2.5) n.s.
Medication adherence6 6.5 (1.4) 6.7 (1.2) 5.5 (1.3) 6.5 (1.3) 6.3 (1.5) 6.5 (1.2) n.s.
1Analyses of Covariance; 2possible range: 6 – 24; 3possible range: 5 – 20; 4possible range: 5 – 25; 5possible range: 6 – 30; 6possible range: 1 (severely lacking
adherence) – 8 (perfect adherence).
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respondents scored the highest possible score on satis-
faction with the rheumatologist, 52% on satisfaction with
the nurse, 30% on trust in the rheumatologist and 29%
on self-efficacy in the patient-provider communication.
This shows that room for improvement on these mea-
sures was limited in our sample. Additionally, 56% of the
respondents had a score of 7 on medication adherence,
with a highest possible score of 8; while this cannot be
defined as a ceiling effect, room for improvement was
limited on this outcome as well.
Discussion
Our study shows that there is a large interest among RA
patients for a hospital-based rheumatology web portal.
More than half of the respondents with Internet access
logged in to the portal, to view their personal data. Of
all the non-users in our sample, only 10% reported not
wanting to use the portal because they were not inter-
ested. The other non-users either had no access to the
Internet, or intended to visit the portal in the future. Re-
ported usage from other studies on patient web portals
with EMR access varies from only 6% [32] to up to 86%
[33]. However, it is difficult to compare the results of
our study with these previous studies, as they differ
widely in types of patient groups and in the additional
services that were provided. Notable is that the portion
of patients in our study that logged in to view their per-
sonal information is much larger than the portion that
only viewed the general information on the patient web
portal. Previous studies have also found that personal
information, and especially laboratory results, are more
useful than general information to patients with chronic
conditions [13]. Concordantly, we can conclude that our
portal with EMR access foresees in a need in these
patients.One of the aims of our study was to investigate deter-
minants of use of the application. Out of all the included
variables, only age was a significant predictor of general
portal use: younger patients were more inclined to visit
the portal. This corresponds to what was found in much
of the previous research on predictors of use of online
applications [16,17,34]. Because the mean age of our
sample was 62, our data shows that older generations in
the Netherlands actively use the Internet, the proportion
of which will only increase in the upcoming generations.
As expected, self-perceived Internet skills and amount of
Internet use significantly predicted logging in on the pa-
tient web portal. Previous research focusing on adoption
of patient web portals, has also found that computer lit-
eracy can be a barrier in the uptake of health technolo-
gies [35,36]. It would be interesting to study whether
more active encouragement and guidance from care pro-
viders towards patients with low (e)health literacy would
affect their interest and use of the application.
Our portal was designed with a strong focus on the end-
user, in which patients were invited to be actively involved
in the determination of the content and the design of the
portal. Also, together with rheumatology care providers,
we made an effort to present up to date DAS28 and lab re-
sults in a clear overview. Previous studies have shown that
care providers are hesitant about patient EMR access be-
cause it could confuse patients [21,37,38], but our results
show that patients found the login part of the portal us-
able and understandable. Additionally, “mistakes” that
were found in the patient-accessible EMR only concerned
data that was slightly outdated and the few patients that
experienced this handled these issues very well. While it
should be noted that our patient-accessible EMR con-
tained only a selection from the full medical records, it
seems that when implemented carefully, expected draw-
backs hardly occur. This confirms that a user-centered
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portals. Further research should also explore care
providers’ experiences with patients who use the portal,
and the changes in work flow that they perceive, in
order to determine to what extent the patient web
portal changes health care processes.
Evaluating the impact of the patient web portal, we
could not find significant differences over time in em-
powerment. Nevertheless, patients that logged in to the
portal did report to perceive a larger involvement in, and
understanding of, their treatment. Patients also reported
that using the login part of the portal improved their
knowledge of their disease and increased their capability
to understand their care providers. Most patients reported
using the login service prior to a consultation, which could
indicate that they used it to prepare for the conversation
with their doctor or nurse [34,38]. Two recent systematic
reviews on the effects of patient web portals with EMR
access show that only a few other studies have included
empowerment-related outcomes into their evaluations,
with small and inconclusive results [13,10]. Tuil et al. [9],
who conducted a study among patients undergoing IVF
treatment, could not detect any enhancement in patient
empowerment over time either. Ross et al. [15], who
evaluated a portal with EMR access among patients with
congestive heart failure, found improvements in medica-
tion adherence and a small trend in increased self-efficacy
and satisfaction with patient-provider communication. In
our study, the lack of change over time might be explained
by the timeframe between both measurements. If the post-
test had been assessed at a later moment in time, through
which patients could have used the portal more regularly,
(especially in relation to more consultations) effects would
perhaps have been more visible. Moreover, the instru-
ments used might not have been responsive enough to
measure a difference. Large ceiling effects were found on
the outcomes before using the patient web portal, leaving
little room for improvement.
When interpreting these results, we should take note
of some limitations. First, a response bias might have
occurred. It is conceivable that patients who completed
the questionnaires were already satisfied and involved
patients, preempting any measurable increase of the
empowerment-related outcomes. Such response bias
should also be mentioned in the light of the usage, satis-
faction and perceived effect of the portal; it is possible
that patients who were more interested in online informa-
tion and support in the first place were more intended to
use the portal, to complete our surveys and to value the
portal positively. Second, this study relied on self-report
measurements; however we are not sure if patients are
able and motivated to make reliable assessments of their
behavior. Future studies using less subjective measures,
such as observations of doctor-patient communications orpill-counting boxes, could reveal whether patients are
actually more knowledgeable about their disease, better
able to speak up to their doctor and more adherent to
medication. Also, observing patients’ portal usage during
assignments might provide a more valuable assessment of
actual web portal usability. From a previous study, it
appeared that patients are not always aware of the
mistakes they make when using the Internet for health-
related purposes [39]. To further enhance the use and
the impact of the portal, more attention might be paid
to its content during consultations, so that patients
might learn how to use the information from their
records for their own benefit [40,41].
Conclusions
In conclusion, a hospital-based rheumatology patient web
portal with EMR access offers rheumatoid arthritis pa-
tients usable and understandable access to personal infor-
mation. While the actual impact on patient empowerment
is difficult to measure, a large portion of patients does feel
more informed and involved in their own treatment due
to the portal.
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